Advertisement
ResearchIn-Press PreviewCell biologyImmunologyOncology
Open Access |
10.1172/JCI204067
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Zhu, L. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Luo, S. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Hua, Q. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Zhao, C. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Lin, H. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Liu, M. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Zhu, L. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Zheng, J. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Feng, H. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by Li, Y. in: PubMed | Google Scholar
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by
Wu, C.
in:
PubMed
|
Google Scholar
|
1School of Life Sciences, Sun Yat-sen University, Guangzhou, China
2Xiangya Cancer Center, Central South University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China
4School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
5Department of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangzhou, China
Find articles by
Zheng, L.
in:
PubMed
|
Google Scholar
|
Published October 6, 2026 - More info
Splenic myelopoiesis supplies immunosuppressive myeloid cells in cancer, yet its local regulation remains unclear. Here we identify a self-amplifying circuit between neutrophils and hematopoietic stem and progenitor cells (HSPCs) that sustains splenic myelopoiesis. Tumor-associated neutrophils produced reactive oxygen species (ROS) and created an oxidatively stressed milieu in the spleen, which activated FOXO1 in neighboring HSPCs and drove DRP1-mediated mitochondrial fission, reprogramming HSPCs toward myeloid-biased expansion and immunosuppressive output. Progeny neutrophils reinforced splenic oxidative stress and perpetuated this loop. Genetic ablation of Cybb or spleen-targeted ROS scavenging inhibited FOXO1 activation and preserved fused mitochondria morphology in HSPCs. Consistently, blockade of FOXO1 or DRP1 prevented mitochondrial fission and reduced ROS-producing myeloid cell generation. Such interventions reduced splenic myelopoiesis, curtailed the production of suppressive myeloid cells in the spleen and their infiltration into tumors, and enhanced cytotoxic T cell activity, thereby restoring antitumor immunity and restraining tumor progression. Analyses of spleen samples from cancer patients, together with cord-blood HSPC and neutrophil co-culture experiments, support the human relevance of this neutrophil–ROS–HSPC axis. These findings reveal a self-propagating neutrophil–HSPC feedback circuit that locally sustains tumor-promoting splenic myelopoiesis and provide a rationale for targeting neutrophil-to-progenitor signaling to normalize antitumor immunity.